Basic Information
Chenomx provides a proprietary platform for generating, categorizing, and interpreting metabolic information obtained from biofluids using nuclear magnetic resonance (NMR) spectroscopy. Chenomx employs patented technology, integrating state-of-the-art spectral processing techniques for identifying metabolic markers and utilizing advanced algorithms to analyze biological samples. Chenomx's flagship software, Chenomx NMR Suite, assists scientists in linking metabolic responses to pathology, toxicity, drug efficacy, and genetics.
Chenomx Inc.
Edmonton,Alberta,Canada
unclear
January 01, 2000
info@chenomx.com

